Microbial Blue Bioprospecting: Exploring the Advances of Compounds Post-Discovery
Marine Drugs · 17.10.2025 · 23 (10) · 406
DOI: 10.3390/md23100406 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Marine Drugs, online erschienen am 17.10.2025. Verfasst von Cristiana Roberta Multisanti und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Sciences, University of Messina, 98168 Messina, Italy. Hauptthemen laut MEDLINE: Biological Products, Aquatic Organisms, Bacteria, Bioprospecting. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 208 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Marine biotechnology is an emerging field of research. There is scientific evidence of the strong potential of a multitude of marine microorganisms in biotechnology, with applications spanning the medical, pharmaceutical, cosmeceutical, nutraceutical and environmental recovery fields. However, despite the discovery of new natural compounds being of wide-ranging benefit, their practical application still remains difficult due to costs and lengthy validation processes. The strength of natural compounds is that, unlike synthetic or already-known compounds, they can have more specific functions and are generally environmentally friendly. This requires, however, that each newly discovered compound be assayed for its toxicity through tests on model cells and organisms. Research should therefore not stop with the simple discovery of new compounds but go beyond with the validation of their efficacy and safety, an issue that remains poorly addressed for products of marine bacterial origin. This review analyses current knowledge on natural compounds of marine bacterial origin, trying to focus on the necessary steps after their discovery, including the investigation of their non-toxicity to model organisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Veterinary Sciences, University of Messina, 98168 Messina, Italy.
- Department of Chemical Biological, Pharmaceutical and Environmental Sciences, University of Messina, Viale Ferdinando Stagno d'Alcontres 31, 98166 Messina, Italy.
- Stazione Zoologica Anton Dohrn, Department of Ecosustainable Marine Biotechnology, Sicily Marine Centre, C. da Porticatello, 29-Villa Pace, 98167 Messina, Italy.
- Department of Biology and Chemistry, Faculty of Natural Sciences, University "Luigj Gurakuqi" of Shkodra, 4000 Shkodra, Albania.
- National Research Council of Italy (CNR), Institute for Organic Synthesis and Photoreactivity (ISOF), Via Piero Gobetti 101, 40129 Bologna, Italy.
- Stazione Zoologica Anton Dohrn-CRIMAC, Department of Integrative Marine Ecology, Calabria Marine Centre, C. da Torre Spaccata, 87071 Amendolara, Italy.
ORCID-Profile: Cristiana Roberta Multisanti, Carmen Rizzo, Caterina Faggio
Zitieren
APA
Multisanti, C. R., Celi, V., Dibra, A., Pintus, A., Calogero, R., Rizzo, C., & Faggio, C. (2025). Microbial Blue Bioprospecting: Exploring the Advances of Compounds Post-Discovery. Marine Drugs, 23(10), 406. https://doi.org/10.3390/md23100406
Vancouver
Multisanti CR, Celi V, Dibra A, Pintus A, Calogero R, Rizzo C, et al. Microbial Blue Bioprospecting: Exploring the Advances of Compounds Post-Discovery. Marine Drugs. 2025;23(10):406. doi:10.3390/md23100406
BibTeX
@article{Multisanti2025,
author = {Multisanti, Cristiana Roberta and Celi, Valeria and Dibra, Aurora and Pintus, Angela and Calogero, Rosario and Rizzo, Carmen and Faggio, Caterina},
title = {Microbial Blue Bioprospecting: Exploring the Advances of Compounds Post-Discovery},
journal = {Marine Drugs},
year = {2025},
volume = {23},
number = {10},
pages = {406},
doi = {10.3390/md23100406}
}
EUVIMED